
Research

Miniature robots on the millimeter scale often lack the strength to transport instruments for endoscopic microsurgery through the body. Scientists at the German Cancer Research Center (DKFZ) are now combining several millimeter-sized TrainBots into one unit and equipping them with improved “feet”. For the first time, the DKFZ team was able to perform an electric […]
read more
Critical Pathway for rare brain tumor discovered
Choroid plexus tumors mainly affect toddlers under one year of age. Scientists at the German Cancer Research Center (DKFZ) have now been able to show that a permanently activated important signaling pathway of intracellular communication is responsible for the development of these rare brain tumors. Tumors of the choroid plexus develop as a result of […]
read more
Language model “UroBot“ surpasses the accuracy of experienced urologists
Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. “UroBot” was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the […]
read more
New Member: Welcome in our cluster to iQMedix GmbH
iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient’s unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer […]
read more
New Member: Welcome in our cluster to !LEVA Sciences GmbH
!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded […]
read more
New Member: Welcome in our cluster to OMNI Life Science GmbH & Co. KG
OLS – OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, […]
read more
New Member: Welcome in our cluster to Daiichi Sankyo Europe GmbH
Daiichi Sankyo’s European roots date back to the 1980s with branches in Düsseldorf. In 1990, Sankyo acquired Luitpold-Werke, a German pharmaceutical company, expanding operations to Pfaffenhofen, Germany, and Altkirch, France. In 2006, Daiichi and Sankyo merged, with European headquarters in Munich. Now present in 13 countries, Daiichi Sankyo employs over 2,000 people, making it one […]
read more
New Member: Welcome in our cluster to SPT Labtech
SPT Labtech transforms the way scientists work by pioneering automation in liquid handling, sample preparation, and management for over 25 years. Their solutions streamline lab tasks, reduce human error, and ensure precise, consistent results. Using positive displacement technology, they enable ultra-low volume accuracy, saving reagents and samples. Their automated systems simplify sample storage and organization, […]
read more
YUMAB and MOLCURE Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets
YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the application of zero-shot AI technology for antibody discovery. The collaboration brings together complementary expertise and technologies. MOLCURE has a decade of experience […]
read more